187 related articles for article (PubMed ID: 33929391)
1. Ozone Attenuated H9c2 Cell Injury Induced by Doxorubicin.
Xu L; Wang C; Zou Z; Wu Z
J Cardiovasc Pharmacol; 2021 Jul; 78(1):e86-e93. PubMed ID: 33929391
[TBL] [Abstract][Full Text] [Related]
2. Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis.
Tavakoli Dargani Z; Singla DK
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H460-H471. PubMed ID: 31172809
[TBL] [Abstract][Full Text] [Related]
3. Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells.
Guo R; Wu K; Chen J; Mo L; Hua X; Zheng D; Chen P; Chen G; Xu W; Feng J
Cell Physiol Biochem; 2013; 32(6):1668-80. PubMed ID: 24356372
[TBL] [Abstract][Full Text] [Related]
4. Human Amnion Membrane Proteins Prevent Doxorubicin-Induced Oxidative Stress Injury and Apoptosis in Rat H9c2 Cardiomyocytes.
Faridvand Y; Haddadi P; Vahedian V; Nozari S; Nejabati HR; Pezeshkian M; Afrasiabi A; Safaie N; Jodati A; Nouri M
Cardiovasc Toxicol; 2020 Aug; 20(4):370-379. PubMed ID: 32086724
[TBL] [Abstract][Full Text] [Related]
5. Docosahexaenoic Acid Attenuates Doxorubicin-induced Cytotoxicity and Inflammation by Suppressing NF-κB/iNOS/NO Signaling Pathway Activation in H9C2 Cardiac Cells.
Wang ZQ; Chen MT; Zhang R; Zhang Y; Li W; Li YG
J Cardiovasc Pharmacol; 2016 Apr; 67(4):283-9. PubMed ID: 26657886
[TBL] [Abstract][Full Text] [Related]
6. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
[TBL] [Abstract][Full Text] [Related]
7. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.
Mukhopadhyay P; Rajesh M; Bátkai S; Kashiwaya Y; Haskó G; Liaudet L; Szabó C; Pacher P
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1466-83. PubMed ID: 19286953
[TBL] [Abstract][Full Text] [Related]
8. Exogenous H2S protects H9c2 cardiac cells against high glucose-induced injury and inflammation by inhibiting the activation of the NF-κB and IL-1β pathways.
Xu W; Chen J; Lin J; Liu D; Mo L; Pan W; Feng J; Wu W; Zheng D
Int J Mol Med; 2015 Jan; 35(1):177-86. PubMed ID: 25412187
[TBL] [Abstract][Full Text] [Related]
9. Ethanol extracts of Rhaponticum uniflorum (L.) DC flowers attenuate doxorubicin-induced cardiotoxicity via alleviating apoptosis and regulating mitochondrial dynamics in H9c2 cells.
Hu B; Zhen D; Bai M; Xuan T; Wang Y; Liu M; Yu L; Bai D; Fu D; Wei C
J Ethnopharmacol; 2022 Apr; 288():114936. PubMed ID: 35007682
[TBL] [Abstract][Full Text] [Related]
10. ERK1/2/p53 and NF-κB dependent-PUMA activation involves in doxorubicin-induced cardiomyocyte apoptosis.
Zhang DX; Ma DY; Yao ZQ; Fu CY; Shi YX; Wang QL; Tang QQ
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2435-42. PubMed ID: 27338072
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of Di'ao Xinxuekang capsule against doxorubicin-induced chronic cardiotoxicity.
Li X; Liang J; Qin A; Wang T; Liu S; Li W; Yuan C; Qu L; Zou W
J Ethnopharmacol; 2022 Apr; 287():114943. PubMed ID: 34954266
[TBL] [Abstract][Full Text] [Related]
12. Sanguinarine Attenuates Lipopolysaccharide-induced Inflammation and Apoptosis by Inhibiting the TLR4/NF-κB Pathway in H9c2 Cardiomyocytes.
Meng YY; Liu Y; Hu ZF; Zhang Y; Ni J; Ma ZG; Liao HH; Wu QQ; Tang QZ
Curr Med Sci; 2018 Apr; 38(2):204-211. PubMed ID: 30074177
[TBL] [Abstract][Full Text] [Related]
13. Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells.
Guo RM; Xu WM; Lin JC; Mo LQ; Hua XX; Chen PX; Wu K; Zheng DD; Feng JQ
Mol Med Rep; 2013 Aug; 8(2):603-8. PubMed ID: 23807148
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-induced apoptosis in H9c2 cardiomyocytes by NF-κB dependent PUMA upregulation.
Li D; Li J; An Y; Yang Y; Zhang SQ
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2323-9. PubMed ID: 24065225
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-9 aggravates doxorubicin-induced cardiotoxicity by promoting inflammation and apoptosis in mice.
Ye D; Wang Z; Xu Y; Ye J; Wang M; Liu J; Zhang J; Zhao M; Chen J; Wan J
Life Sci; 2020 Aug; 255():117844. PubMed ID: 32464124
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA miR-215-5p Regulates Doxorubicin-induced Cardiomyocyte Injury by Targeting ZEB2.
Xiong X; He Q; Liu J; Dai R; Zhang H; Cao Z; Liao Y; Liu B; Zhou Y; Chen J; Chen M; Liu J
J Cardiovasc Pharmacol; 2021 Oct; 78(4):622-629. PubMed ID: 34282068
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
Zhang QL; Yang JJ; Zhang HS
Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of let-7f-2-3p by long noncoding RNA NEAT1 inhibits XPO1-mediated HAX-1 nuclear export in both in vitro and in vivo rodent models of doxorubicin-induced cardiotoxicity.
Liu Y; Duan C; Liu W; Chen X; Wang Y; Liu X; Yue J; Yang J; Zhou X
Arch Toxicol; 2019 Nov; 93(11):3261-3276. PubMed ID: 31570982
[TBL] [Abstract][Full Text] [Related]
19. Change in TNF-alpha receptor expression is a relevant event in doxorubicin-induced H9c2 cardiomyocyte cell death.
Chiosi E; Spina A; Sorrentino A; Romano M; Sorvillo L; Senatore G; D'Auria R; Abbruzzese A; Caraglia M; Naviglio S; Illiano G
J Interferon Cytokine Res; 2007 Jul; 27(7):589-97. PubMed ID: 17651020
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
